Neurobiologocal mechanisms of presynaptic metabolic adaptation and their organization: implications for a pathophysiology of the affective disorders.
D000222:Adaptation, Physiological; D000342:Affective Symptoms / Q000503:physiopathology*; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001679:Biogenic Amines / Q000502:physiology; D002395:Catecholamines / Q000378:metabolism; D004361:Drug Tolerance; D006801:Humans; D008094:Lithium / Q000494:pharmacology; D008566:Membranes / Q000201:enzymology; D018377:Neurotransmitter Agents / Q000096:biosynthesis; D011619:Psychotropic Drugs / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012701:Serotonin / Q000502:physiology; D013569:Synapses / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D009435:Synaptic Transmission; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology
D000596:Amino Acids; D001679:Biogenic Amines; D002395:Catecholamines; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D012701:Serotonin; D008094:Lithium